Sengkang General Hospital will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg

Hepato-pancreato-biliary (HPB) Service

Synonym(s):

The Hepato-pancreato-biliary service in Sengkang General Hospital (SKH) specialises in the management of benign and malignant (cancerous) conditions affecting the liver, pancreas, gallbladder and bile ducts. 

Such diseases are often complex and require multidisciplinary, coordinated care. We work closely with our colleagues from Gastroenterology, Radiology and Medical Oncology to provide the full spectrum of management options. Cases are regularly discussed in multidisciplinary team meetings in order to tailor-make comprehensive, evidence-based care plans for each and every patient.

Our team of surgeons is highly experienced at performing complex operations of the liver, pancreas, bile ducts and gallbladder, having trained both locally and internationally in high-volume centers. We offer both open and minimally-invasive (laparoscopic) surgical procedures for treatment of these conditions. The use of minimally-invasive procedures benefits patients by allowing smaller incisions, reduced post-operative pain, faster recovery and a shorter hospital stay.

If you have questions, or want to learn more about the diagnosis and treatment of diseases of the liver, pancreas, bile ducts or gallbladder, make an appointment with the SKH Hepato-pancreato-biliary team. You may also attain a referral from your family physician, the polyclinic or your local GP clinic.

 

Our Approach

Each patient's treatment is overseen by our surgeons and is supported by a multidisciplinary team comprising but not limited to:

  • Interventional GI endoscopists
  • Gastroenterologists
  • Radiologists (Diagnostic / Interventional)
  • Oncologists
  • Nurse practitioners and oncology nurses


This collaborative approach ensures that patients are provided with timely diagnosis and individualised care in order to achieve the best possible outcomes.

 

 

Our Clinical Services

We offer clinical consultation and evaluation of patients with the following symptoms /complaints:

  • Abdominal pain / discomfort / bloatedness
  • Dyspepsia / indigestion / frequent belching
  • Abdominal swelling/mass
  • Gallstones / bile duct stones
  • Jaundice
  • Anaemia
  • Vomiting
  • Unexplained weight loss
  • Loss of appetite
  • Groin swelling
  • Raised tumour markers
 

 

FAQs

What are some common hepato-pancreato-biliary (HPB) conditions?

One of the most common benign HPB conditions is gallstones and its related conditions. Gallstones frequently present with pain and upper abdominal bloatedness. Gallstones can also result in cholecystitis, cholangitis and pancreatitis. The management of symptomatic / complicated gallstone disease is surgery to remove the gallbladder and the stones.

Primary malignant diseases of the HPB include hepatocellular carcinoma (liver cancer), pancreatic adenocarcinoma (pancreas cancer) and cholangiocarcinoma (bile duct cancer). Though uncommon, prompt diagnosis and treatment is required to ensure the best outcomes for patients.

What are some symptoms that I should look out for?

Symptoms related to HPB diseases can include, but are not limited to:

  • Abdominal pain
  • Abdominal swelling
  • Dark-colored urine
  • Jaundice—a yellowing of the skin and the whites of the eyes
  • Pale-coloured or bloody stool
  • Loss of appetite or unexplained weight loss

If you are experiencing any  of these symptoms, seek medical attention immediately.

 

How are liver, pancreatic, biliary & related diseases diagnosed?

Each consult begins by your doctor taking a detailed medical history and performing a thorough physical examination. We may also ask about your personal medical history as well as family history to determine if you are at higher risk for specific disorders. This is usually followed by additional diagnostic modalities such as blood tests, cross-sectional imagining and biopsies.

What treatments are available for hepato-pancreato-biliary diseases?

Today, there is an extensive array of surgical and non-surgical options available for the management of hepato-pancreato-biliary diseaes. As mentioned, the team works closely with several disciplines in order to provide high-quality, evidence-based, patient-centred care. When surgery is required, both minimally invasive as well as conventional approaches may be considered as appropriate.

 

Our Care Team

News

针对癌症高风险者 本地推出两旗舰研究 评估癌症测试技术和筛查效用
Patient Care 针对癌症高风险者 本地推出两旗舰研究 评估癌症测试技术和筛查效用 本地癌症发病率持续上升,癌症筛查率却始终偏低。为突破这一防癌瓶颈,本地医疗科研团队宣布启动两项计划,招募有患癌风险的公众参与,探讨如何借助新型检测技术与个性化方案,更早发现癌症隐患.
14 May 2026 | Lianhe Zaobao Read Story
Patient Care Singapore to trial multi-cancer early detection tests and targeted cancer screening A clinical study involving 1,000 people at higher risk of cancer due to genetic factors or pre-cancerous conditions will be carried out in the second half of 2026 to evaluate the use of popular multi-cancer early detection (MCED) tests.
14 May 2026 | The Straits Times Read Story
Announcements NCCS and NTU Singapore-led Cancer Prevention Research Institute Launches Studies to Evaluate Multi-Cancer Early Detection Tests and Tackle Metabolic Dysfunction-Linked Cancers in Singapore The Research Institute for Cancer Prevention, Screening and Early Detection (RISE), jointly led by the National Cancer Centre Singapore (NCCS) and Nanyang Technological University, Singapore (NTU Singapore), has announced the launch of two studies; one led by NCCS to evaluate multi-cancer early detection (MCED) tests and another led by the Lee Kong Chian School of Medicine (LKCMedicine) at NTU Singapore to develop targeted screening and prevention for metabolic dysfunction-linked cancers in Singapore.
13 May 2026 Read Story